GlaxoSmithKline Buys New Vaccine Developer Affinivax in $3.3 Billion Deal
The vaccine is currently in clinical trials has been “well tolerated in participants and demonstrated good immune responses,” according to the company. And a lot of money is riding on the success of that vaccine, as $1.2 billion hangs in the balance if the vaccine receives full approval from the FDA.
“Affinivax grew out of our founders’ scientific and personal vision to drive vaccine innovation to make a meaningful impact on people’s lives, in both developed and developing countries,”“Over the past eight years, we have taken that vision from the initial development of our MAPS™ vaccine platform at Boston Children’s Hospital to a pipeline of novel vaccines with our lead vaccine candidate in late-stage clinical studies,” Brugger continued.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Crypto exchange WhiteBit buys Ukraine's Eurovision trophy in auction for armed forcesThe Estonian exchange paid more than $900,000 for the glass trophy in an auction to raise funds for the Ukrainian army.
Lire la suite »
Norwegian settles dispute with Boeing and buys 50 737 Max jetsNorwegian Air has agreed to buy 50 Boeing 737 Max 8 aircraft and secured options for a further 30 of the planes at an undisclosed price, ending a contract dispute between the two companies, the budget carrier said on Monday.
Lire la suite »
Kava Onboards Sushi With $14M in Developer Incentive FundingThe integration will allow Sushi users and developers to have seamless access to the entire $300 billion market value of Ethereum and Cosmos from a single network.
Lire la suite »
Israel signs landmark free trade agreement with UAEThe deal eliminates bilateral tariffs on 96 percent of goods and aims to boost trade volume between the two countries to up to $10 billion.
Lire la suite »
Long COVID risk falls only slightly after vaccination, huge study showsVaccination against SARS-CoV-2 lowers the risk of long COVID after infection by only about 15%, according to a study of more than 13 million people
Lire la suite »
Apple’s RealityOS for rumored headset appears in trademark applicationAhead of Apple’s developer conference next week.
Lire la suite »